BerganT.: Pharmacokinetics of a new cephalosporin, CGP 9000 (Cefroxadine) in healthy volunteers. Pharmacology, 26; 225 (1980).
2.
HirtzJ., LecaillonJ. B., GerardinA., SchoellerJ. P., HumbertG., GuibertJ.: Pharmacokinetics of a new cephalosporin, CGP 9000, in humans. Curr. Chemother. Infect. Dis., Proc. 11th Intern. Congr. Chemotherapy Boston, 1; 211 (1979).
3.
HoltH. A., BroughallJ. M., FüllhaasJ., BiniA. J., ReevedD. S.: Multidose human pharmacology of CGP 9000 in volunteers. Curr. Chemother., Proc. 10th Intern. Congr. Chemotherapy Zurich, 2; 829 (1977).
4.
KisslingM., XilinasM., GlausL.: Efficacy and tolerability of CGP 9000 (Oraspor) in diabetic patients treated for urinary tract infections: a case control study. Pharmather., 2; 575 (1981).
5.
NakayamaI., KawaguchiH., IshiyamaS.: Comparative study on different assays of CGP 9000 and CGP 3940. Curr. Chemother. Infect. Dis., Proc. 11th Int. Congr. Chemotherapy Boston, 1; 209 (1979).
6.
O'CallaghanC. H.: Description and classification of the newer cephalosporin and their relationship with the established compounds. J. Antibiot. Chemother., 5; 635 (1979).
7.
RugendorffE. W., RöhrbornC., RugendorffK.: Clinical comparison of CGP 9000 and Cephalexin in out-patients with urinary tract infections. Abstr. 2nd Mediterranean Congr. Chemotherapy, Nice 1980.
8.
SoranzoM. L., BosioG., BramatoC., SalassaB., AndriniL., EandiM.: Ricerca clinica su una nuova cefalosporina: CGP 9000 (cefroxadina). Minerva med., 72; 813 (1981).
9.
StegerW., GlausL.: CGP 9000 in the therapy on uncomplicated urinary-tract infections. Abstr. 2nd Mediterranean Congr. Chemotherapy, Nice 1980.
10.
ToschW., FehlmannH., ZakO.: Antibacterial effects of CGP 9000 in human urine in vitro. Curr. Chemother. Infect. Dis., Proc. 11th Intern. Congr. Chemotherapy Boston, 1; 213 (1979).
11.
VischerW. A., ZakO., KonopkaE. A., FehlmannH., RegösJ., ToschW.: Experimental evaluation of CGP 9000 a new orally active cephalosporin. Curr. Chemother., Proc. 10th Intern. Congr. Chemotherapy Zurich, 2; 825 (1977).
12.
WirzH., VischerW. A., FüllhaasJ., ImhofP. R.: Pharmacokinetics of CGP 9000, a new orally active cephalosporin, in healthy volunteers. Curr. Chemother., Proc. 10th Intern. Congr. Chemotherapy Zurich, 2; 827 (1977).
13.
ZakO., VischerW. A., SchenkC., ToschW., ZimmermannW., RegösJ., SuterE. R., KradolferF., GelzerJ.: CGP 9000, a new orally active, broad-spectrum cephalosporin. J. Antibiot., 29; 653 (1976).
14.
ZakO., ToschW., VischerW. A., KradolferF.: Comparative experimental studies on 3-methoxy and 3-methyl cephems. Drug exp. clin. Res., 3; 11 (1977).
15.
ZakO., KradolferF.: Effects of subminimal inhibitory concentrations of antibiotics in experimental infections. Rev. Infect. Dis., 1; 862 (1979).